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chrome C release and inhibition of pathological apoptosis (2.6% to 12.4%, SWOP vs. 
sham) during the late phase of ischemic preconditioning. Opening the permeability tran- 
sition pore before the sustained ischemia on day 2 with the PTP activator lonidamine (10 
mg/kg body weight) completely abolished these cyto protective effects of SWOP. Conclu- 
sion: The present study thus suggest the potential role of PTP in mediating the protection 
during second window of ischemic preconditioning by up regulating the Bcl-2 expresslo”. 
1132-130 C(-260)+T Polymorphism in the Promoter of CD14 
Receptor Gene Is Associated With the Risk of Acute 
Coronary Events in Patients With Angina Pectoris 
Ramon Arrovo-Espliouerq Eugenia Vazquez-Rey, Khaled El-Sharnouby, Kamini 
Kalidas, Juan R. Gimsno-Blanes, Della Cole, Steve Jeffery, Juan C. Kaski, St. George’s 
Hospital Medical School, London, United Kingdom 
Background: Inflammation and infection have been suggested to play a role in athero- 
sclerosis and Its complvzations. The CD14 receptor is a mediator for the activation of 
monocytes by lipopolysaccharide of gram-negative bacteria. The T allele of the C(- 
260)-T polymorphism in the promoter of CD14 receptor gene has been shown to 
enhance transcriptional actiwty and expresion of CD14 receptor on monocyies. The aim 
of this study was to assess whether this polymorphism is associated with increased risk 
of developing acute coronary syndromes (ACS) and atherosclerosis. 
Methods: We studied 428 patients who underwent heart catheterization between 1994 
and 1997. Stenoses 2 50% in at least one coronary artery were seen in 334 patients, 
whereas 94 had a normal angiogram. Patients with coronary artery disease were subdi- 
vided in two groups: 1) no hlstory of ACS (n: 140; 64i9 years; men: 79%) and 2) patients 
with a hlstory of ACS (n: 194; 64*9 years; men: 80%). CD14 genotypes were determined 
by a Polymerase Chain Reaction technique (PCR-RFLP). Genotype frequencies 
between different groups were compared by the x2-test and logistic regression adjusted 
by age, body mass index and conventional cardiovascular risk factors 
Results: Genotypes were in Hardy-Weinberg equilibrium. Patients with prior ACS had a 
significantly higher frequency of the T/l genotype than patients without a history of ACS 
(33% vs. 20.0%; P=O.O09). After adjustment, genotype TIT was found to be an indepen- 
dent risk factor for ACS (OR 1 84 11.1 to 3.11 Cl 95%; P=O.O23). When normal patients 
and patients with prior ACS were compared, the OR after adjustment was 3.1 [1.3 to 7.41 
Cl 95% (/X0.012). Tfl genotype was not significantly different between patients without 
a history of ACS and normal patients (20.0% vs. 22.3%; P&67). 
Conclusions: C(-260) +T polymorphrsm in the promoter of the CD14 gene is associated 
with a history of ACS. and It may represent a genetically determined risk factor for ACS. 
The response of monocytes to infectious stimuli determined by this polymorphism could 
play an important role in atheromatous plaque vulnerability. 
1132-131 Extrinsic Rapid Electrical Stimulation Modulates 
Sarcoplasmic Reticulum Ca’*Regulatory Proteins in 
Cultured Rat Cardiomyocytes 
Tomoko Nao, Tomoko Ohkusa, Nonko Inoue, Tomo Matsumoto. Dong Jing Yao, Yuji 
Hisamatsu, Masafumi Yano, Masunori Matsuzaki, Yamaguchi Unwersity Graduate 
School of Medicine, Ube, Japan 
Background: Tachycardia is commonly present in patients with heart failure (HF). How- 
ever, its role in the development of failing myocardlum has received little attention. We 
studied the effects of rapid electrical stimulation (RES) of contraction on sarcoplasmic 
reticulum (SR) Ca2+ regulatory proteins in cardiomyocytes in vitro. Methods: Neonatal rat 
ventricular.myocytes were cultured as confluent monolayers and then subjected to RES 
(3.OHz) for up to 180 min. The expression of SR Cap+-ATPase (SERCA), ryanodine 
receptor (RyR) and inositol 1,4.5-trisphosphate receptor type 1 (IP3R) were identified by 
Western blot method and RT-PCR. Contraction and relaxation characteristics of cardi- 
omyocytes were monltored with contractility data acquisition systems. Results: The 
expression of SERCA protein significantly increased after 60 min compared wrth control 
(0.50+0.17 YS 0.24+0.08, pc.05). and Its level returned to the control level after 180 min 
stimulation. The expression of SERCA mRNA tended to decrease after 160 min of RES, 
though not significantly, compared with control. The expression of RyR protein signifi- 
cantly increased after 180 min (1.76kO.56 vs 0.68iO.45, p<.O5), however RES did not 
affect the expression of RyR mRNA. RES also caused a significant increase in IP3R pro- 
tein expression, however its mRNA level significantly decreased after 180 min 
(0.034+0.017 vs 0.084r0.049. pc.05). There were no significant differences in terms of 
the time to peak tension, the time to 70% tension-regresslon. departure velocity, and 
return velocity. Conclusion: In the early stage of RES, in vitro, the expression of SR Ca2+ 
regulatory proteins was compensated due to decreased protein degradation in a different 
time course, leadlng to the maintenance of contraction-relaxation characteristics. 
1132-132 Glycoprotein 130 Mediated Induction of Vascular 
Endothelial Growth Factor in Human Adult Cardiac 
Myocytes 
Thomas W. Weiss, Walter S. Speidl, Christoph Kaun, Jan Bialy, Christoph Springer, 
Gerald Maurer, Kurt Huber. Johann Wojta, University of Vienna, Vienna, Austria 
Background: Vascular endothelial growth factor (VEGF-A) is an endothelium-specific 
growthfactor. It Induces proliferation, migration and NO-synthesis in endothelial cells and 
is able to stimulate neoangiogenesis in ischemic organs. A significant increase of VEGF- 
A serum levels was shown after myocardial infarction. These data suggest the impor- 
tance of the VEGF system during reperaration and neovascularization. Recent data 
showed that glycoprotein 130 (gpl30) is involved in the regulation of VEGF-A. Therefore 
we investigated whether oncostatin-m (OSM) or Leukemia Inhibitory Factor (LIF) are 
possible regulators of VEGF-A in Human adult cardiac myocytes (HACM) in vitro and 
thus mrght contribute to the neoangiogenesis during cardiac repair processes. 
Methods: HACM were isolated from recipients’ hearts after heart transplantation and 
characterized by positwe staining for actin, troponin-I and cardiotin. The cells were nega- 
tive for two fibroblast-specific antibodies as well as for desmin and vWF indicating the 
absence of fibroblasts, smooth muscle cells and endothelial cells. Such characterized 
HACM were treated with OSM or LIF for 24 hours and VEGF-A was determmed by a 
specific ELISA in the conditioned media of these cells. We performed a RT-PCR in order 
to detect gpl30. Interleukin-6-receptor (IL-6R), LIF-receptor (LIFR) or OSM-receptor 
(OSMR). 
Results: We showed that OSM, but not LIF Increased VEGF-A expressron in HACM 
dose-dependently. The effect of OSM could be reversed using AG490, a specific JAK 
InhIbitor, indicating that OSM increases VEGF-A expression via the JAWSTAT pathway. 
These results could be confirmed on the level of specific mRNA expression as deter- 
mined by RT-PCR. We detected the expression of gp130 and OSMR and to a lesser 
extent LIFR and IL-6-R on HACM by RT-PCR. 
Conclusion: Our data suggest, that selective expression of the 11-6 superfamiliy-receptors 
on cardiac myocytes might be involved in the induction of VEGF-A medlated neoangio- 
genesls in the heart. 
1132-133 Trace Element Analysis of Hair Samples in Coronary 
Artery Disease Add Diagnostic Yield at a Bargain 
Robert W. Biederman Mark Doyle, Drane Vido, Edwin W. Biederman, Jr., Allegheny 
General Hospital, Pittsburgh, PA, The Pennsylvania State University, University Park, PA 
INTRODUCTIONTrace elements (TE) have been implicated in the pathogenesis of dw 
eases including cancer (Se), diabetes (Ch), and CAD (Fe). The link is causal in some: 
Keshan disease (Se), and associative in others; Down’s syndrome (Ca). Further, specific 
interactions are not well understood, in part related to complexities of traditional harvest- 
Ing, preparation and analysis of low concentration samples. Clearly, an improved method 
would be advantageous. Since hair samples offer an atraumatic technique with a ten-fold 
higher concentration of TE than serum, we investrgated the feasibility of TE analysis in 
hair of pts with documented (CAD). 
HYPOTHESISWe hypothesized that wng a new, highly sensitive technique, Inductively 
Coupled Plasma Mass-Spectrophotometer (ICP), TE may offer a novel non-invaswe and 
inexpensive manner in which to screen populations for CAD. 
METHODS Above root hair was obtained in 20 subjects; IO pts with simultaneous routine 
cardiac catheterization and lesions >GO%(CAD+). Ten subjects without clinical evidence 
of CAD served as controls(CAD-). Analysis was conducted on a double focwng sector 
field resolution ICP with a linear dynamic range greater than 100. Multr-element screen- 
mg of 16 TE’s (Cd, Co, Cr, Cs, Cu, Fe, Mg, Mn, Pb, Rb, Sb, Se, Sn, Sr, TI. end Zn) with 
ultra-high resolution and low dark noise resulted in detection of TE to peg/L. Calibrated 
preparation: acetone, double distilled 60, and digestion with 20% high purity NH@ at 
60°C for 2 weeks prior to analysis. Mann-Whitney U and Newman-Keuls were used to 
test for significance. 
RESULTS No significant relationship of TE with HTN, diabetes, race or family history 
was found. However, TE concentrations diverged between the CAD+ and the CAD- 
group in 14 of 16 TE’s. Mean TE concentratrons in the CAD+ patients were lower than 
CAD- pabents in Cd, Co. Cr, Cs, Cu, Fe, Mg, Mn, Pb, Rb, Sb, Se, Sn, and Zn and higher 
for Sr and TI (pqO.05). Analysis cost: $9.37/ hair sample. 
CONCLUSION Trace element hair sample analysis by Inductively Coupled Plasma- 
Mass Spectrophotometer with a standardized preparation offers the potential for additive 
noninvasive, inexpensive and sensitive information in the evaluation of patients with sus- 
pected CAD. 
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1133-117 Repeated Exposure to Caffeine Increases Arterial 
Stiffness 
Charalambos Vlachopoulos Andriana Sofianidou, Foteini Kosmopoulou, Christodoulos 
Stefanadis, Michael O’Rourke. Pavlos Toutouzas. Athens Medical School, Athens, 
Greece, University of New South Wales, Sydney, Australia 
Background: Caffeine (C) is the most widely consumed pharmacological substance. 
Wave reflectron (WR) along the arterial tree, an Important index of arterial stiffening and 
cardiac afterload, is involved in the pathogenesis of hypertensron. We studied the effect 
of C on WR and especially that of repeated exposure because of the possible tolerance 
that develops to C. 
Methods: Twelve healthy volunteers (age 29i4 yrs) were studied I” a randomized, pla- 
cebo-controlled, crossover fashion (100 mg of C orally -equivalent to 1 cup of coffee- and 
120 min later another 100 mg of caffeine). WR was evaluated using a validated system 
(Sphygmocor@) that employs (i) high-fidelity arterial tonometry for the non-invasive regis- 
tration of arterial pulse and (ii) appropriate computer software for pulse wave analysis. 
Augmentation index (Alx) was measured as an index of WR. 
Results: The first dose of C led to a substantial increase in Alx lndlcating increased 
effect of WR from the periphery. The second dose increased Alx again, but to a lesser 
extent (figure). Aortic pressures also increased (systolic: by 2.6 with the I” dose and by 
2.7 mmHg with the 2”d; diastolic: by 4.3 and by 1 .B,mmHg respectively). 
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Conclusions: A regular dose of C increases WR. A second dose consumed shortly after 
produces a smaller but discernible adverse effect on WR adding up to a prolonged total 
effect. This finding has impoltant implications for arterial stiffening and the pulsatile load 
of the heart and may be involved in the pathogenesis of hypertension. 
1133-118 Changes in Lefl Ventricular Structure and Function 
Predict the Onset of Hypertension in Adult 
Normotensives With a Family History of Hypertensive 
Disease: A Seven-Year Follow-Up Study 
Dan Blendea Caius Duncea, Stuarl &rich. Sorin Crisan, Minodora Bedreaga. Roman 
Vlaicu. University of Medicine and Pharmacy, Cluj-Napoca, Romania, Bridgeport 
Hospital, Bridgeport. CT 
Background: Alterations in left ventricular (LV) structure and function have been previ- 
ously shown in normotensive offspring of hypertensive (HT) families but their significance 
is still unclear. 
Methods: To verify if these alterations have predictive value for the onset of HT disease, 
205 norrnotensive adults (mean age 43+/-10 yrs) with family history of HT. were exam- 
ined echocardiographically (2D, M mode, Doppler) at baseline and then repeatedly at 12 
months intewals, during a follow-up period of 7.1 yrs (range 4-7.5 yrs). 
Results: During this period, 57 subjects (26%) became hypertensive (H group). These 
subjects had higher values for the baseline LV mass index (LVMl)(97 +/- 25 g/m2 YS 81 
+/- 21 g/m2: p<O.Ol), lower age adjusted E/A ratios (1.1 +/- 0.4 vs 1.4 +/- 0.4; p<O.OOl). 
and lower LV longitudinal fractional shortening (0.16 +/- 0.03 vs 0.19 +/- 0.03; p=O.O36) 
compared to those who did not develop HT (N group). The subjects in the H group had 
also higher initial systolic blood pressure (SBP) (134 +/- 12 mmHg vs 117 +/- 11 mmHg; 
pcO.01) and a higher number of 1 st degree relatives with HT (2.9 +/- 0.3 vs 1.5 +I- 0.4 ; 
p= 0.044). 
There was no significant difference in baseline LVEF, LV clrcumferentlal fractIonal short- 
ening, LV and diastolic diameter and left atrial size between H and N subjects at base- 
line. 
SBP at the end of the follow-up was predicted independently by the initial SBP 
(beta=0.359; pcO.Ol), age (beta 0.01, p=O.O42) and LVMI (beta=0.165; p<O.Ol). 
During the follow-up period, the subjects who subsequently developed HTN. experienced 
a significant increase in LVMI (from 97+/-25 g/m2 to 104 +/- 26 g/m2; p=O.O39), and 
increase in aortic diameter (from 32 +/- 4 mm to 36 +I- 6 mm; pcO.01). The paired differ- 
ences for all these parameters were significantly higher in the H group compared to the N 
group. H subjects had also higher variations in LV-E/A between the echo exams in the 
follow-up period when compared to the N group (coeff var 25% vs 12%; pcO.01). 
Conclusions: Increased LV mass and alterations in LV diastolic and systolic longitudinal 
function predict the onset of HT in normotensives with family history of HT. Increased 
variability in LV diastolic function seem to appear during the period of developing HT. 
1133-119 N-Terminal Pro-Brain Natriuretic Peptide Predicts 
Cardiovascular Events in Hypertension: A LIFE 
Substudy 
Michael H. Olsen, Kristian Wachtell, Christian Tuxen, Eigil Fossum. Lia E. Bang, 
Christian Hall. Hans Ibsen. Jens Rokkedal. Richard B. Devereux. Per Hildebrandt 
Glostrup University Hospital, Copenhagen, Denmark, Frederiksberg University Hospital, 
Copenhagen, Denmark 
Background: N-terminal pro brain natriuretic peptide (NT-proBNP) is a strong cardio- 
vascular risk factor in patients with chronic heart failure as well as in the general popula- 
tion. We wanted to investigate whether high NT-proBNP could predict the composite 
endpoint (CEP) of cardiovascular death, non-fatal stroke or non-fatal myocardial infarc- 
tion in patients with hypertension and left ventricular hyperlrophy as well. Methods: After 
two weeks of placebo treatment and yearly for 4-5 years clinical, laboratory, and 
echocardiographic variables were assessed in 164 hypertensive patients from the LIFE 
Echo substudy, aged 55-60 (mean 66~7) years. with electrocardiographic LV hypettro- 
phy. NT-proBNP was measured by immunoassay (Elecsys proBNP) at baseline and after 
one year of treatment. 
Results: CEP occurred in 25 patients. Baseline NT-proBNP above the median value of 
165 pg/ml was associated with higher incidence of CEP (16.7% vs 6.7%, P<O.O5). 
Known cardiovascular disease (n=60) defined as diabetes (n=20), or history of either 
ischemic heart disease (n=26), cerebrovascular disease (n=l9), peripheral vascular dis- 
ease (n=5) or chronic heart failure (n=2). was also associated with higher incidence of 
CEP (24.6% vs. 8.9%, P<O.Ol). NT-proBNP above the median value was not associated 
with higher incidence of CEP in this high-risk group (24.3% vs. 21.7%, NS), but was in 
the remaining 124 “low-risk” hypertensive patients (14.6% vs. 4.3%, kO.01). In Cox 
regression analyses controlling for treatment assignment NT-proBNP (PcO.05) predicted 
CEP slightly more strongly than prior cardiovascular disease (kO.054) and current/prior 
smoking (P=O.O6). Systolic blood pressure, gender and body mass index did not enter 
the model. NT-proBNP levels after one year of treatment also tended to predict the CEPs 
that occurred subsequently (18.6% vs. 9.2%, P=O.O7). Conclusion: NT-proBNP is a 
Strong cardiovascular risk factor in patients with hypwtension and LV hypemophy, espe- 
cially in the group without diabetes or clinically overt cardiovascular disease. Further- 
more, our data suggest the possible use of NT-proBNP - even measured dunng 
treatment. as a practical tool for risk stratification in hypertension. 
1133-146 Genetic Analysis of Multiple Risk Factor Syndrome in 
Rats 
Takehiro Watanabe, Yi-Qiang Liang. Hyoe Inomata, Kazuyuki Yanai, Yoko lizuka, 
Takanari Gotoda, Norihiro Kate, International Medical Center of Japan, Tokyo, Japan, 
Tokyo University, Tokyo, Japan 
Background: According to epidemiological studies, cardiovascular risk factors tend to 
cluster in certain individuals, which has been widely recognized as the multiple risk factor 
syndrome. To clarity pathophyslological mechanisms underlying the multiple risk factor 
syndrome, we performed extensive genetic analysis using a unique model organism, the 
spontaneously hypertensive rat (SHR). 
Methods: We undertook genome-wide screens in 2 F2 cohorts independently produced 
from the Wistar-Kyoto rat and SHR of a Japanese colony (151 males in F2-1 and 175 
males in F2-2). In addition to blood pressure. plasma lipid, glucose and insulin levels, 
and body weight, in vitro phenotypes associated with insulin resistance and fat pad 
weight were evaluated in F2-1, while part of F2-2 (n=32) were fed high-fat-high-choles- 
terol (HFHC) diet between 15 and 17 weeks of age. 
Results: In the entire progeny, the most significant linkage to blood pressure was found 
near D3Mitl4 on rat chromosome 3 (maximal LOD score=5.0), where linkage to triglycer- 
ide levels was concomitantly observed. Also, suggestive linkage was observed for blood 
pressure and cholesterol levels on rat chromosome 19. Significant linkage to body weight 
was observed near DZMit5 on rat chromosome 2 (maximal LOD score=4.0 in FZ-2). 
There was a suggestive evidence of linkage to in vitro phenotypes, i.e., glucose uptake 
and lipolysis measured in isolated adipocytes, in a region between D4Mghl7 and 
D4Mghll on rat chromosome 4. far distant from the Cd36 locus. In several chromosomal 
regions, statistical significance of lknkage was enhanced after HFHC diet. 
Conclusion: We have identified the clustering of linkages to more than 1 phenotypic traits 
on a few chromosomes, suggesting the potential existence of genes controllmg multiple 
cardiovascular risk factors at least in rats. Our data also provide a substantial evidence 
for a gene-environment interaction, that is, some quantitative trait loci become prominent 
after a certain dietary intewention. Further investigation including the development of 
congenic strains is currently in progress to resolve these issues. 
1133-147 Cardiovascular Morbidity and Mortality in Hypertensive 
Patients With Atrial Fibrillation: The LIFE Study 
Kristian Wachtell. Bjijrn Horn&am, Mika Lehto, David J. Slotweiner, Eva Gerdts, Peter 
Aurup, Bjijrn DahlW, Hans Ibsen, Steve Julius, Sverre E. Kjeldsen. Markku S. Niemlnen, 
Jens E. Rokkedal, Richard 8. Devereux, Glostrup University Hospital, Glostrup, 
Denmark, The Weill Medical College of Cornell University, New York, NY 
Background: OptImaI treatment of hypertensive patients with atrial fibrillation (AF) to 
reduce the risk of cardiovascular morbidity and mortality remains unclear. 
Methods: As part of the LIFE study, 324 patients (42% women) with AF and hyperten- 
sion (mean age 70+6, pressure 176+14196+10 mmHg) and electrocardiographic left ven- 
tricular (LV) hypertrophy, were assigned to losartan- or atenolol-based therapy for 1,365 
patient-years of follow-up. 
Results: The primary composite endpoint occurred in 36 patients in the losartan-group 
(n=l50) vs. 64 in the atenolol-group (wl74); relative risk (RR) 0.60 [95% Cl 0.40.0.921. 
P=O.O18. Cardiovascular deaths occurred I” 20 vs. 37 patients in the losartan- and 
atenolol-group, respectively: RR 0.58 [Cl 0.34-I ,011, P=O.O53. Stroke occurred in 16 vs. 
37 patients (RR 0.56 [Cl 0.31.0.971, P=O.O40), and myocardlal infarction in 11 vs. 7 
patients (P=NS). There was a trend towards lower all-cause mortality; 30 vs. 46 (RR 0.67 
[Cl 0.43.1.071, P=O.O92), and hospitalization for heart failure took place in 15 vs. 23 
patients (P=NS). Adjustment for blood pressure levels during follow-up had little impact 
on cardiovascular benefit of losartan. 
Conclusion: Los&an was more effective than atenolol-based therapy in reducing the 
risk of the primary composite endpoint of cardiovascular morbidity and mortality as well 
as the secondary endpoints of stroke and cardiovascular death, I” hypertensive patients 
with electrocardiographic LV hypertrophy and AF and there was a trend towards lower 
ail-cause mortality. Hypertensive patients with electrocardiographic LV hypertrophy and 
AF seem to benefit more, for the same blood pressure lowering, from losartan than from 
conventional antihypertensive and antiarrhyihmic treatment by atenolol. 
1133-148 Cardiovascular Safety of Vardenafil in Patients 
Receiving Antihypertensive Medications: A Post-Hoc 
Analysis of Five Placebo-Controlled Clinical Trials 
Robert A. Kloner, Puneet Mohan, Thomas Segerson, Marc Thibonnier, Christ&w 
Norenbarg, Harin Padma-Nathan, Good Samaritan Hospital, Los Angeles, CA, The Male 
Clinic, Beverly Hills, CA 
Background: Hypertension is associated with erectile dysfunction (ED). Phosphodi- 
esterase-5 (PDEd) inhibitors may potent&e blood pressure (BP) reduction of antihyper- 
tensive agents (HTM). This study evaluated the cardiovascular safety of vardenafil, a 
potent, selective PDE-5 inhibitor when used with HTM. 
Methods: Data ware extracted from 5 double-blind Phase Ill trials in which 2,716 men 
with ED received vardenafil 5, 10, or 20 mg or placebo as needed for up to 26 weeks. 
Adverse events and vital signs were tabulated at all visits; in a patient subgroup (n=703), 
vital signs were recorded 11 min to 5 h post-dose. Vardenafil doses were pooled and 
analyzed by HTM use. 
Results: In 2,605 patients valid for safety (vardenafil-1,812, placebo-793), 21 HTM was 
